Sign in
Art Zeile

Art Zeile

President and Chief Executive Officer at DHI GROUPDHI GROUP
CEO
Executive
Board

About Art Zeile

Art Zeile (age 61) has served as President & CEO and a director of DHI Group (DHX) since April 2018. He holds a B.S. in Astronautical Engineering from the U.S. Air Force Academy and an MPP from Harvard University, with prior CEO roles at HOSTING (cloud services), QTC Management, and co-founder/CEO of Inflow (data centers), and service in the U.S. Air Force (1986–1993) . Under his leadership, DHI’s FY2024 revenue declined 7% to $141.9M while Adjusted EBITDA margin improved to 25% (vs. 24% in 2023), and annual bonuses paid at 92.7% of target; PSUs earned at 79.3% based on Bookings performance . The company reports five-year cumulative TSR down 41% versus peer group up 77% .

Past Roles

OrganizationRoleYearsStrategic Impact
HOSTING (cloud computing)CEO2008–2016Roll-up strategy in U.S. cloud services; focus on security/compliance for mission-critical web apps
QTC Management Inc. (healthcare tech)CEO2006–2007Led healthcare technology firm
Inflow Inc. (public data centers)Co-founder & CEO1997–2005Built public data center operator
United States Air ForceOfficer1986–1993Astronautical engineering background; military leadership experience

External Roles

OrganizationRoleYearsCommittees / Responsibilities
National Bank Holdings Corporation (NYSE: NBHC)DirectorSince 2016Audit; Nominating/Governance; Chair of Compensation Committee
Element CriticalChairman of the BoardOct 2019–Oct 2023Oversight of data center operator

Fixed Compensation

MetricFY 2022FY 2023FY 2024
Salary ($)550,000 577,500 577,500
Non-Equity Incentive ($)960,142 521,648 535,249
Stock Awards ($)1,724,195 2,704,500 1,778,000
All Other Compensation ($)21,491 22,366 22,891
Total ($)3,255,828 3,826,014 2,913,640

Additional parameters for FY2024:

  • Base salary: $577,500
  • Target bonus: 100% of salary ($577,500)
  • Actual bonus payout: 92.7% of target ($535,249)

Performance Compensation

ProgramMetricWeightingTargetActualPayoutVesting
Senior Bonus Plan (FY2024)Revenue50%$148.4M $141.9M Pro-rata if ≥85%; overall plan funded 92.7% Cash (annual)
Senior Bonus Plan (FY2024)Adjusted EBITDA & Margin50%EBITDA ≥ $34.455M and Margin ≥ 24% (after plan payout) EBITDA $35.3M; Margin 25% (after payout) Fully earned if both thresholds met; overall plan funded 92.7% Cash (annual)
Long-Term PSUs (2024 grant)Bookings100% of PSU component$153.3M $140.6M 79.3% achievement Earned PSUs vest 1/3 on 1st, 2nd, 3rd anniversaries of grant/certification

2024 grant specifics (Zeile):

  • Grant date: Jan 26, 2024
  • Restricted stock: 350,000 shares; vests one-third annually over 3 years
  • PSUs granted: 350,000; earned at 79.3% → 277,484 PSUs
  • Annual bonus funded at 92.7% across NEOs

Stock vested during 2024:

  • Shares vested: 542,010; value realized: $1,335,128 (gross)

Clawback: DHI adopted an Exchange Act Rule 10D-1 compliant clawback policy effective Oct 2, 2023; legacy clawback applies pre-10/2/2023 awards .

Equity Ownership & Alignment

HolderShares of Common StockUnvested Restricted StockTotal Beneficially Owned% of Outstanding
Art Zeile2,728,121 558,334 3,286,455 6.8% (based on 48,275,693 shares outstanding)

Unvested awards outstanding as of Dec 31, 2024 (market value uses $1.77/share):

Grant TypeGrant DateUnvested UnitsMarket Value ($)
Restricted Stock1/25/202244,500 78,765
Restricted Stock2/3/2023150,000 265,500
Restricted Stock1/26/2024350,000 619,500
Earned PSUs1/25/2022122,628 217,052
Earned PSUs2/3/202399,764 176,582
Earned PSUs1/26/2024277,550 491,264

Ownership guidelines:

  • CEO must hold ≥3.0x base salary; directors ≥3.0x retainer; all are compliant or within phase-in .

Hedging/pledging:

  • Company prohibits hedging and purchasing on margin, short sales, or derivatives by directors/officers/employees or related parties .

Employment Terms

ScenarioCash SeveranceMedical/Dental (COBRA)Equity AccelerationTotal
Termination without cause or for good reason (no CoC)$577,500 $14,084 Restricted stock: $963,765; PSUs governed by award terms $1,555,349
Termination within 12 months post Change-of-Control$1,155,000 (base + target bonus) $14,084 Restricted stock: $963,765; earned CIC PSUs: $884,824 $3,017,673

Key contract provisions:

  • Non-compete and non-solicit: 12 months post-termination .
  • COBRA reimbursement for 12 months upon qualifying termination .
  • Change-of-control PSU treatment: prorated “earned CIC PSUs” convert and vest service-based monthly to 3rd anniversary; full acceleration if terminated within 12 months post-CoC .

Board Governance

  • Zeile is a Class I director (term expiring 2026), not independent; no committee memberships .
  • Board structure: independent Chair (Brian “Skip” Schipper), 7 of 8 directors independent; independent standing committees; regular executive sessions of independent directors .
  • Meetings: Board met 11 times in 2024; all directors attended ≥75% of meetings; Audit Committee met 8x; HCC Committee 5x; N&CG Committee 2x .
  • Director compensation: employee-directors (including Zeile) receive no additional director pay .

Performance & Track Record

MetricFY 2023FY 2024
Revenues ($M)151.9 141.9
Net Income ($M)3.5 0.3
Adj. EBITDA ($M)36.3 35.3
Adj. EBITDA Margin (%)24% 25%

Other disclosures:

  • 2024 renewal rates: ClearanceJobs 95%, Dice 78%; retention rates 111% (CJ), 98% (Dice); leverage ratio 0.9x Adjusted EBITDA; year-end cash $3.7M; total debt $32M .
  • Say-on-Pay approval ~80% in 2024 .

Recent strategic/operating context (2025 YTD):

  • Q3 2025: revenue $32.1M (-9% YoY); Adjusted EBITDA margin 32%; Dice margin expanded; impairment of Dice trade name; new $5M share repurchase authorized Nov 2025 .
  • Zeile commentary: rising AI-related postings (>50% of postings involved AI projects by Oct 2025); CJ positioned at intersection of defense/security/tech; evaluating adjacencies including ATS acquisition (AgileATS) .

Compensation Structure Analysis

  • Mix: For CEO, ~79% variable in 2024; emphasis on PSUs tied to Bookings and restricted stock with 3-year vesting (pay-for-performance retention) .
  • Metrics: Annual plan uses revenue and Adjusted EBITDA/Margin with explicit thresholds and caps; 2024 paid at 92.7% of target (despite revenue decline) due to margin delivery .
  • Equity: No options granted in recent years; awards are restricted stock and PSUs; repricing prohibited; robust clawback policies enacted .
  • Peer benchmarking: Detailed peer group; program reviewed with independent consultant (Compensia) .
  • Share ownership: CEO beneficial ownership of ~6.8% aligns incentives; hedging/margin transactions prohibited .

Director Compensation (for context; Zeile receives none)

NameCash Fees FY2024 ($)Stock Awards FY2024 ($)Total ($)
Non-employee directors (sample)46,250–81,250 110,000 156,250–191,250

Program overview: service fee $40,000; chair and committee fees; annual restricted stock grant (44,177 shares) vesting in 12 months .

Investment Implications

  • Alignment: Zeile’s high equity ownership (6.8%), ownership guidelines, and prohibition on hedging/margin support alignment; PSUs tied to Bookings give leverage to top-line growth resumption .
  • Retention/Severance: Standard non-compete/non-solicit; CoC terms include 1x salary+target bonus and full equity acceleration, potentially incentivizing support for value-creating transactions but also increasing event-driven dilution risk .
  • Performance signals: Bonuses funded near target on margin delivery despite revenue decline; PSUs at 79.3% suggest moderated long-term payout; large annual vesting volumes (542K shares vested in 2024) can create technical selling pressure around vest dates .
  • Governance: Independent chair reduces dual-role concerns; say-on-pay ~80% indicates acceptable shareholder support; Section 382 rights plan adopted (Jan 2025) to preserve $108.7M capital loss carryforwards—reduces change-in-control probabilities at low ownership thresholds (4.99%) and may affect stock liquidity/technical setup .
  • Tactical: Company-authorized buybacks in 2025 ($5M program) and margin expansion at Dice amid AI-driven postings may support near-term share price, but bookings softness and brand-specific impairments highlight execution risk .